You are here

  • Home
  • Archive
  • Volume 9, Issue 6
  • Circulating myeloid-derived suppressor cells and regulatory T cells as immunological biomarkers in refractory/relapsed diffuse large B-cell lymphoma: translational results from the R2-GDP-GOTEL trial

Article metrics

Article menu

Download PDFPDF

XML
Immunotherapy biomarkers
Original research
Circulating myeloid-derived suppressor cells and regulatory T cells as immunological biomarkers in refractory/relapsed diffuse large B-cell lymphoma: translational results from the R2-GDP-GOTEL trial

 

Online download statistics by month:

Online download statistics by month: June 2021 to September 2024

AbstractFullPdf
Jun 2021371376186
Jul 2021313313124
Aug 2021175175144
Sep 202111711673
Oct 202117317387
Nov 202112212356
Dec 202113213453
Jan 202211312047
Feb 2022758142
Mar 2022697637
Apr 202210410828
May 2022707647
Jun 2022808740
Jul 2022535419
Aug 2022727430
Sep 2022586129
Oct 2022626540
Nov 2022595928
Dec 2022474917
Jan 2023545523
Feb 2023757514
Mar 2023485016
Apr 2023192019
May 2023333616
Jun 20232132147
Jul 202333533545
Aug 202324249
Sep 2023313116
Oct 2023292929
Nov 2023545421
Dec 2023303018
Jan 2024646523
Feb 2024454519
Mar 2024434325
Apr 2024585824
May 2024343215
Jun 2024383721
Jul 2024525323
Aug 20245859144
Sep 20242828261
Total363036931915